In HNSCC, deregulation ofmiR-183-5p and its target gene ASNS has been documented in aradiochemotherapy cell culture model of primary HNSCC cells and is a potentialprognostic marker for radiochemotherapy outcome (Summerer et al., 2015). The gene discussed is ASNS; the disease is head and neck squamous cell carcinoma.